Chanfreau, C., Lynch, K. E., Chang, J., Becker, D. J., Friedman, D. R., Rivera, D., … Lynch, J. A. (2018). Chronic myeloid leukemia among veterans from 2006-2015: Trends in utilization of tyrosine kinase inhibitors. In Journal of Clinical Oncology (Vol. 36, pp. e18832–e18832). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.e18832

Chanfreau, Catherine, Kristine E. Lynch, Jiwon Chang, Daniel Jacob Becker, Daphne Ruth Friedman, Donna Rivera, Scott DuVall, and Julie Ann Lynch. “Chronic myeloid leukemia among veterans from 2006-2015: Trends in utilization of tyrosine kinase inhibitors.” In Journal of Clinical Oncology, 36:e18832–e18832. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e18832.

Chanfreau C, Lynch KE, Chang J, Becker DJ, Friedman DR, Rivera D, et al. Chronic myeloid leukemia among veterans from 2006-2015: Trends in utilization of tyrosine kinase inhibitors. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e18832–e18832.

Chanfreau, Catherine, et al. “Chronic myeloid leukemia among veterans from 2006-2015: Trends in utilization of tyrosine kinase inhibitors.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. e18832–e18832. Crossref, doi:10.1200/jco.2018.36.15_suppl.e18832.

Chanfreau C, Lynch KE, Chang J, Becker DJ, Friedman DR, Rivera D, DuVall S, Lynch JA. Chronic myeloid leukemia among veterans from 2006-2015: Trends in utilization of tyrosine kinase inhibitors. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e18832–e18832.